Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginia F Borges

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 15, 2017
Biology and Etiology of Young-Onset Breast Cancers among Premenopausal African American Women: Results from the AMBER ConsortiumLynn Chollet-Hinton, Andrew F Olshan, Hazel B Nichols, et al.
Journal of the National Cancer Institute|May 19, 2026
Pregnancy history, recency of childbirth, and outcomes in young women with early-stage breast cancerGuilherme Nader-Marta, Yue Zheng, Shoshana M Rosenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2019
NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2Louis Fehrenbacher, Reena S Cecchini, Charles E Geyer, et al.
Breast Cancer Research and Treatment|November 5, 2020
Response to neoadjuvant chemotherapy and the 21-gene Breast Recurrence Score test in young women with estrogen receptor-positive early breast cancerTal Sella, Shari I Gelber, Philip D Poorvu, et al.
NPJ Breast Cancer|October 5, 2024
Clinical and immune responses to neoadjuvant fulvestrant with or without enzalutamide in ER+/Her2- breast cancerAnthony D Elias, Alyse W Staley, Monica Fornier, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2016
Identification of shared TCR sequences from T cells in human breast cancer using emulsion RT-PCRDaniel J Munson, Colt A Egelston, Kami E Chiotti, et al.
Current Oncology (Toronto, Ont.)|May 26, 2026
Cancer During Pregnancy: Navigating Clinical and Research ChallengesMackenzie K Callaway, Lizelle Comfort, Dhivyaa Anandan, et al.
NPJ Breast Cancer|May 20, 2023
Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancerAnthony D Elias, Nicole S Spoelstra, Alyse W Staley, et al.
Journal of the National Cancer Institute|January 9, 2026
Postpartum breast cancer: evidence for a distinct phenotypeMark E Sherman, Lola Etievant, Robert A Vierkant, et al.
NPJ Breast Cancer|January 24, 2025
Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypesFresia Pareja, Rohit Bhargava, Virginia F Borges, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 15, 2017
Biology and Etiology of Young-Onset Breast Cancers among Premenopausal African American Women: Results from the AMBER ConsortiumLynn Chollet-Hinton, Andrew F Olshan, Hazel B Nichols, et al.
Journal of the National Cancer Institute|May 19, 2026
Pregnancy history, recency of childbirth, and outcomes in young women with early-stage breast cancerGuilherme Nader-Marta, Yue Zheng, Shoshana M Rosenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2019
NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2Louis Fehrenbacher, Reena S Cecchini, Charles E Geyer, et al.
Breast Cancer Research and Treatment|November 5, 2020
Response to neoadjuvant chemotherapy and the 21-gene Breast Recurrence Score test in young women with estrogen receptor-positive early breast cancerTal Sella, Shari I Gelber, Philip D Poorvu, et al.
NPJ Breast Cancer|October 5, 2024
Clinical and immune responses to neoadjuvant fulvestrant with or without enzalutamide in ER+/Her2- breast cancerAnthony D Elias, Alyse W Staley, Monica Fornier, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2016
Identification of shared TCR sequences from T cells in human breast cancer using emulsion RT-PCRDaniel J Munson, Colt A Egelston, Kami E Chiotti, et al.
Current Oncology (Toronto, Ont.)|May 26, 2026
Cancer During Pregnancy: Navigating Clinical and Research ChallengesMackenzie K Callaway, Lizelle Comfort, Dhivyaa Anandan, et al.
NPJ Breast Cancer|May 20, 2023
Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancerAnthony D Elias, Nicole S Spoelstra, Alyse W Staley, et al.
Journal of the National Cancer Institute|January 9, 2026
Postpartum breast cancer: evidence for a distinct phenotypeMark E Sherman, Lola Etievant, Robert A Vierkant, et al.
NPJ Breast Cancer|January 24, 2025
Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypesFresia Pareja, Rohit Bhargava, Virginia F Borges, et al.
Pageof 14